Pharma & Biotech

Investors in pharmaceutical leader AbbVie are navigating a period of significant uncertainty as the company approaches its third-quarter earnings release....

Assembly Biosciences is experiencing a substantial equity rally, fueled by encouraging clinical trial outcomes and reinforced confidence from financial analysts....

As markets await forthcoming quarterly results, BioNTech is signaling its strategic direction beyond the pandemic era. The German biopharmaceutical company...

The biotechnology firm aTyr Pharma faces an unprecedented crisis as its stock value collapses and legal challenges mount. This dramatic...

Keros Therapeutics Inc. has become the center of intense market attention following the announcement of a substantial capital return program...

The biotechnology sector has found a promising contender in Axsome Therapeutics. This US-based pharmaceutical company continues to post impressive achievements...

While much of the biotechnology sector is focused on the upcoming ESMO congress in Berlin, Incyte has already scored a...

The biotechnology sector has identified its latest standout performer: Ideaya Biosciences. While numerous companies in the space face developmental challenges,...

Danaher Corporation faces heightened investor scrutiny as a legal investigation emerges just days before the company's critical third-quarter earnings announcement....

The biotechnology firm Atossa Therapeutics is positioning itself for a significant transition, yet market participants remain divided on its prospects....